Cargando…

Carmustine and methotrexate in combination after whole brain radiation therapy in breast cancer patients presenting with brain metastases: a retrospective study

BACKGROUND: Since 1999, patients presenting with brain metastases (BM) from breast cancer (BC) are treated in our institution with a carmustine (BCNU) - methotrexate (MTX) combination. We report here our clinical experience regarding this combination. PATIENTS AND METHODS: Patients were treated by a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jacot, William, Gerlotto-Borne, Marie-Cécile, Thezenas, Simon, Pouderoux, Stéphane, Poujol, Sylvain, About, Mahdi, Romieu, Gilles
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2887781/ https://www.ncbi.nlm.nih.gov/pubmed/20525352 http://dx.doi.org/10.1186/1471-2407-10-257

Ejemplares similares

Comparative performances of prognostic indexes for breast cancer patients presenting with brain metastases
por: Braccini, Antoine-Laurent, et al.
Publicado: (2013)

Preservation of neurocognitive function and local control of 1 to 3 brain metastases treated with surgery and carmustine wafers
por: Brem, Steven, et al.
Publicado: (2013)

Safety and efficacy of carmustine (BCNU) wafers for metastatic brain tumors
por: Ene, Chibawanye I., et al.
Publicado: (2016)

Whole-brain radiation therapy for brain metastases: detrimental or beneficial?
por: Gemici, Cengiz, et al.
Publicado: (2015)

The role of whole brain radiation therapy in the management of melanoma brain metastases
por: Dyer, Michael A, et al.
Publicado: (2014)

Variations in whole brain radiation therapy fractionation for brain metastases in Victoria
por: Chee, Lessandra Yan Shan, et al.
Publicado: (2022)

The prognostic value of the Tau protein serum level in metastatic breast cancer patients and its correlation with brain metastases
por: Darlix, Amélie, et al.
Publicado: (2019)

Carmustine Wafer Implantation at the Era of Standardized Chemoradiation Protocol
por: Roux, Alexandre, et al.
Publicado: (2019)

Shifting paradigms: whole brain radiation therapy versus stereotactic radiosurgery for brain metastases
por: Shinde, Ashwin, et al.
Publicado: (2019)

Integration of stereotactic radiosurgery or whole brain radiation therapy with immunotherapy for treatment of brain metastases
por: Su, Zhou, et al.
Publicado: (2020)

Carmustine-Induced Phosphatidylserine Translocation in the Erythrocyte Membrane
por: Jilani, Kashif, et al.
Publicado: (2013)

Whole brain radiotherapy with radiosensitizer for brain metastases
por: Viani, Gustavo Arruda, et al.
Publicado: (2009)

Comparison of whole brain radiation therapy for synchronous brain metastases with irradiation protecting the hippocampus versus whole brain radiotherapy for sequential brain metastases to boost irradiation in the treatment of brain metastases from SCLC: study protocol for a randomized controlled trial
por: Zhang, Xiaofang, et al.
Publicado: (2022)

Clinical features of brain metastases in breast cancer: an implication for hippocampal-sparing whole-brain radiation therapy
por: Wu, San-Gang, et al.
Publicado: (2016)

Estimating prognosis at the time of repeat whole brain radiation therapy for multiple brain metastases: The reirradiation score
por: Logie, Natalie, et al.
Publicado: (2017)

Lack of EGFR-activating mutations in European patients with triple-negative breast cancer could emphasise geographic and ethnic variations in breast cancer mutation profiles
por: Jacot, William, et al.
Publicado: (2011)

Adverse Event with the Use of Carmustine Wafers and Postoperative Radiochemotherapy for the Treatment of High-grade Glioma
por: Salle, Federico, et al.
Publicado: (2018)

Serum HER2 extra-cellular domain, S100ß and CA 15-3 levels are independent prognostic factors in metastatic breast cancer patients
por: Darlix, Amélie, et al.
Publicado: (2016)

Changes in vitamin D and calcium metabolism markers in patients undergoing adjuvant chemotherapy for breast cancer
por: Viala, Marie, et al.
Publicado: (2021)

Additional radiation boost to whole brain radiation therapy may improve the survival of patients with brain metastases in small cell lung cancer
por: Sun, Han, et al.
Publicado: (2018)

The benefit of whole brain reirradiation in patients with multiple brain metastases
por: Ozgen, Zerrin, et al.
Publicado: (2013)

Clinical Features of Brain Metastases in Small Cell Lung Cancer: an Implication for Hippocampal Sparing Whole Brain Radiation Therapy()
por: Guo, Wen-Long, et al.
Publicado: (2016)

Bevacizumab and gefitinib enhanced whole-brain radiation therapy for brain metastases due to non-small-cell lung cancer
por: Yang, R.F., et al.
Publicado: (2017)

Radiation Necrosis – A Growing Problem in a Case of Brain Metastases Following Whole Brain Radiotherapy and Stereotactic Radiosurgery
por: Song, Yee Pei, et al.
Publicado: (2018)

3D Radiation Therapy Boost Improves the Outcome of Whole Brain Radiation Therapy Treated RPA II Patients with One or Two Brain Metastases
por: Antoni, Delphine, et al.
Publicado: (2014)

Predictors for Long-Term Survival Free from Whole Brain Radiation Therapy in Patients Treated with Radiosurgery for Limited Brain Metastases
por: Gorovets, Daniel, et al.
Publicado: (2015)

A Randomized Controlled Open-Label Pilot Study of Simvastatin Addition to Whole-Brain Radiation Therapy in Patients With Brain Metastases
por: El-Hamamsy, Manal, et al.
Publicado: (2016)

Cerebral Infarction Related to Carmustine Wafers in Glioblastoma: A Case Report
por: Nakada, Mitsutoshi, et al.
Publicado: (2014)

Ipilimumab and radiation therapy for melanoma brain metastases
por: Silk, Ann W, et al.
Publicado: (2013)

Hypofractionated Radiation Therapy for Large Brain Metastases
por: Masucci, Giuseppina Laura
Publicado: (2018)

Editorial: Effects of radiation therapies on brain metastases
por: Kotecha, Rupesh, et al.
Publicado: (2023)

Single institutional outcomes of whole brain radiotherapy for metastatic melanoma brain metastases
por: Jiang, Cecilia, et al.
Publicado: (2021)

PRO: Do We Still Need Whole-Brain Irradiation for Brain Metastases?
por: Popp, Ilinca, et al.
Publicado: (2023)

Whole Brain Radiation Therapy Plus Stereotactic Radiosurgery in the Treatment of Brain Metastases Leading to Improved Survival in Patients With Favorable Prognostic Factors
por: Khan, Muhammad, et al.
Publicado: (2019)

Blood-brain barrier permeability of gefitinib in patients with brain metastases from non-small-cell lung cancer before and during whole brain radiation therapy
por: Zeng, Yin-duo, et al.
Publicado: (2015)

Carmustine enhances the anticancer activity of selenite in androgen-independent prostate cancer cells
por: Thamilselvan, Vijayalakshmi, et al.
Publicado: (2012)

The Combination of Carmustine Wafers and Fotemustine in Recurrent Glioblastoma Patients: A Monoinstitutional Experience
por: Lombardi, Giuseppe, et al.
Publicado: (2014)

Whole Brain Radiation Therapy Plus Focal Radiation Boost May Generate Better Survival Benefit for Brain Metastases From Non-small Cell Lung Cancer
por: Ni, Meng, et al.
Publicado: (2020)

BRCA1 promoter hypermethylation, 53BP1 protein expression and PARP-1 activity as biomarkers of DNA repair deficit in breast cancer
por: Jacot, William, et al.
Publicado: (2013)

Focal radiation necrosis of the brain in patients with melanoma brain metastases treated with pembrolizumab
por: Du Four, Stephanie, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_50gdqkniksegqdusp8nk8mb8c0